Skip to main content

and
  1. Article

    A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus

    Microalbuminuria is considered the first clinical sign of kidney dysfunction and is associated with a poor renal and cardiovascular prognosis in type 2 diabetes. Detection of patients who are prone to develop ...

    S. S. Roscioni, D. de Zeeuw, M. E. Hellemons, H. Mischak, P. Zürbig in Diabetologia (2013)

  2. Article

    Open Access

    High serum potassium levels after losartan can reflect more severe renal disease. Reply to Gonçalves AR, El Nahas AM [letter]

    S. S. Roscioni, Y. Miao, D. de Zeeuw, H. J. Lambers Heerspink in Diabetologia (2011)

  3. Article

    Open Access

    Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

    Y. Miao, D. Dobre, H. J. Lambers Heerspink, B. M. Brenner, M. E. Cooper in Diabetologia (2011)

  4. Article

    Open Access

    Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

    To assess the effect of an angiotensin receptor blocker (ARB) on serum potassium and the effect of a serum potassium change on renal outcomes in patients with type 2 diabetes and nephropathy.

    Y. Miao, D. Dobre, H. J. Lambers Heerspink, B. M. Brenner, M. E. Cooper in Diabetologia (2011)

  5. No Access

    Article

    Renal failure induces telomere shortening in the rat heart

    BackgroundRenal failure aggravates pathological cardiac remodelling induced by myocardial infarction (MI). Cardiac remodelling is associated with telomere shortening, a marker for biological ageing. We investigat...

    L. S. Wong, W. A. Windt, A. J. Roks, R. P. van Dokkum in Netherlands Heart Journal (2009)

  6. Article

    Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

    We explored the impact of baseline left ventricular hypertrophy (LVH) and losartan treatment on renal and cardiovascular (CV) events in 1,513 patients from the Reduction of Endpoints in NIDDM with the Angioten...

    G. Boner, M. E. Cooper, K. McCarroll, B. M. Brenner, D. de Zeeuw in Diabetologia (2005)

  7. Article

    40th EASD Annual Meeting of the European Association for the Study of Diabetes

    M. Veitenhansl, K. Stegner, F.-X. Hierl, C. Dieterle, H. Feldmeier, B. Gutt in Diabetologia (2004)

  8. Article

    35th Annual Meeting of the European Association for the Study of Diabetes

    A. Melander, J. Olsson, G. Lindberg, A. Salzman, T. Howard, P. Stang in Diabetologia (1999)

  9. No Access

    Article

    ACE inhibitors and proteinuria

    This review discusses the clinical consequences of uninary protein loss and the effects of inhibitors of the angiotensin converting enzyme (ACE) on this clinical finding. Proteinuria appears to be an important...

    R. T. Gansevoort, D. de Zeeuw, P. E. de Jong in Pharmacy World and Science (1996)

  10. No Access

    Article

    Abstracts of papers and posters

    R. L. Anthonio, A. T. M. Willemsen, T. Visser, A. van Waarde in Pharmacy World and Science (1994)

  11. No Access

    Article

    Abstracts of papers and posters Meeting on Pharmaceutical Sciences

    Russell C. Coile Jr., K. Wiedhaup, Ilva van Bommel in Pharmacy World and Science (1993)

  12. No Access

    Article

    Abstracts of papers

    P. A. v. d. Wouw, H. H. v. Rooy, R. W. Koster, A. J. Porsius in Pharmaceutisch Weekblad (1985)